Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Influenza Hemagglutinin (HA) Peptide: Precision Tag for P...

    2026-03-12

    Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Purification and Interaction Studies

    Overview: The Principle Behind the Influenza Hemagglutinin (HA) Peptide

    The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid peptide derived from the epitope region of the influenza hemagglutinin protein. This compact molecular biology peptide tag is widely adopted for its ability to facilitate protein detection, purification, and elution in a variety of biochemical workflows. By leveraging competitive binding to anti-HA antibodies, the HA tag peptide enables researchers to selectively isolate HA-tagged fusion proteins—streamlining immunoprecipitation and protein-protein interaction studies across diverse applications, from signaling pathway mapping to exosome biology.

    High solubility (≥100.4 mg/mL in ethanol, ≥55.1 mg/mL in DMSO, and ≥46.2 mg/mL in water), coupled with ultra-high purity (>98% by HPLC and mass spectrometry), ensures the HA fusion protein elution peptide delivers both consistency and flexibility in experimental design. Supplied by APExBIO, the HA tag’s robust properties make it a cornerstone tool for researchers seeking reliability and reproducibility in complex molecular workflows.

    Step-by-Step Protocol Enhancements Using the HA Tag Peptide

    1. Construct Design: Incorporating the HA Tag

    To leverage the HA peptide as an epitope tag for protein detection, researchers typically engineer the ha tag sequence (YPYDVPDYA) into the coding region of their gene of interest. This can be achieved via PCR-based cloning, using the corresponding ha tag dna sequence (TACCCATACGATGTTCCAGATTACGCT), or by synthesizing gene blocks that include the ha tag nucleotide sequence. The small size of the hemagglutinin tag minimizes interference with protein folding or function, making it ideal for fusion constructs.

    2. Expression and Lysis

    Express HA-tagged proteins in suitable cell lines (e.g., HEK293, HeLa). Upon harvesting, lyse cells using buffers compatible with downstream immunoprecipitation with anti-HA antibody. The high solubility of the ha peptide ensures it can be readily incorporated into a variety of lysis and wash buffers without precipitation.

    3. Immunoprecipitation (IP) and Wash Steps

    Incubate cleared lysates with anti-HA magnetic beads or conventional anti-HA antibody-conjugated agarose. The specificity of the influenza hemagglutinin epitope-tag interaction ensures efficient capture of HA-tagged proteins. After binding, perform stringent washes to reduce background, leveraging the HA peptide’s ability to remain soluble and active throughout buffer exchanges.

    4. Competitive Elution of HA Fusion Proteins

    To elute bound HA-tagged proteins, introduce the synthetic HA peptide into the bead-protein complex. The peptide competes with immobilized HA fusion proteins for anti-HA antibody binding sites, resulting in the gentle, non-denaturing release of intact target proteins. Typical elution concentrations range from 0.1–1 mg/mL, with the peptide’s high solubility allowing for precise titration to optimize yield and purity.

    5. Downstream Applications

    Eluted proteins can be analyzed by SDS-PAGE, Western blotting, mass spectrometry, or functional assays. The use of the HA tag peptide ensures reproducibility and efficiency in workflows such as co-immunoprecipitation for protein-protein interaction studies, or affinity purification for structural and functional analyses.

    Advanced Applications and Comparative Advantages

    Exosome Pathway Dissection

    Recent advances in exosome biology, such as those detailed in the landmark study "RAB31 marks and controls an ESCRT-independent exosome pathway", have highlighted the need for precise, reliable tagging strategies when isolating low-abundance or membrane-associated proteins. The HA tag peptide is particularly valuable in these contexts, allowing for robust immunoprecipitation of HA-tagged exosomal proteins without perturbing their native conformation or interactions. This facilitates the study of protein sorting, trafficking, and secretion mechanisms in complex vesicular transport systems.

    Comparative Performance Insights

    A comparative analysis featured in "Solving Lab Assay Challenges with Influenza Hemagglutinin..." demonstrates that the APExBIO HA tag peptide (SKU A6004) consistently outperforms less pure or less soluble alternatives, resulting in up to 30% higher recovery rates during immunoprecipitation and a notable reduction in background signal. These attributes are critical for experiments where signal-to-noise ratio and sensitivity are paramount, such as in cell signaling or protein-protein interaction studies.

    Complementary and Extended Methods

    The review "Influenza Hemagglutinin (HA) Peptide: Optimizing Protein ..." complements this approach by detailing how superior solubility and validated purity of the HA tag streamline immunoprecipitation and enhance reproducibility—attributes that extend to signal transduction and cancer pathway elucidation. Meanwhile, "Influenza Hemagglutinin (HA) Peptide: Advanced Strategies..." builds upon these foundations, correlating HA tag peptide technology with emerging tools for exosome pathway analysis and advanced purification strategies, thus broadening the scope of potential applications.

    Customizable for Diverse Molecular Workflows

    Whether used as a protein purification tag, as an epitope tag for protein detection, or as a competitive elution reagent, the HA peptide adapts to both standard and high-throughput platforms. Its compatibility with automated liquid handling and multiplexed IP assays makes it a go-to choice for laboratories scaling up their protein interaction screens or proteomics pipelines.

    Troubleshooting and Optimization Tips

    Maximizing Elution Efficiency

    • Optimize peptide concentration: Begin with 0.5 mg/mL and titrate upward for challenging targets. Excess peptide does not typically inhibit downstream detection but may dilute the eluted sample.
    • Buffer compatibility: The HA peptide’s broad solubility profile supports use in water, DMSO, or ethanol-based buffers. For sensitive proteins, consider physiological pH and ionic strength to preserve activity.

    Ensuring Reproducibility

    • Batch consistency: Use high-purity, validated lots such as those from APExBIO to minimize variability.
    • Minimize freeze-thaw cycles: Aliquot peptide stocks and store desiccated at -20°C. Avoid long-term storage of peptide solutions to maintain competitive binding efficiency.

    Reducing Background and Non-Specific Binding

    • Stringent washing: Increase wash stringency (e.g., higher salt or detergent) if non-specific proteins are co-eluting.
    • Validate antibody specificity: Use well-characterized anti-HA antibodies or magnetic beads to reduce off-target interactions.

    Addressing Low Recovery or Yield

    • Check fusion construct expression: Confirm expression and proper folding of the HA-tagged protein by Western blot prior to IP.
    • Troubleshoot elution conditions: Extend elution time or increase HA peptide concentration for stubbornly retained proteins.

    Future Outlook: Expanding the Role of HA Tag Peptide in Molecular Biology

    The ongoing evolution of structural biology, interactomics, and exosome research continues to drive demand for versatile, high-performance peptide tags. The Influenza Hemagglutinin (HA) Peptide is uniquely positioned to support emerging workflows, including CRISPR-based tagging, live-cell imaging, and multiplexed proteomic screens. As highlighted in the thought-leadership article on translational research, the HA tag bridges mechanistic biochemistry with clinical discovery—enabling robust, scalable, and reproducible protein detection and purification across research disciplines.

    Future iterations may incorporate engineered variants of the HA tag for enhanced binding specificity, orthogonal elution profiles, or integration with next-generation detection platforms. As single-cell and vesicular biology continue to advance, the HA tag’s minimal footprint and proven track record ensure it will remain foundational to molecular biology experimentation.

    Conclusion

    The Influenza Hemagglutinin (HA) Peptide, as supplied by APExBIO, delivers unmatched reliability in immunoprecipitation with anti-HA antibodies, competitive binding in elution workflows, and versatility as a molecular tag. Whether dissecting protein-protein interaction networks, purifying exosomal cargoes, or engineering novel fusion constructs, this peptide tag stands as an essential tool for modern molecular biology. For detailed specifications or to order, visit the Influenza Hemagglutinin (HA) Peptide product page.